Latest Pharmaceutical manufacturing News
China pushes emergency use of COVID vaccine despite concerns
BEIJING (AP) — After the first shot, he had no reaction. But Kan Chai felt woozy following the second dose of a COVID-19 vaccine approved for emergency use in China. “When I was driving on the road, I suddenly felt a bit dizzy, as if I was driving drunk," the popular writer and columnist recounted...
Trump's $200 prescription cards won't hit mailboxes just yet
WASHINGTON (AP) — If you’re on Medicare, don’t run to the mailbox looking for a $200 prescription drug card courtesy of President Donald Trump. Government officials said Friday that key details of Trump's election-year giveaway still have to be fleshed out, including the exact timing and how...
The Latest: Concerns over coronavirus upticks in California
SACRAMENTO, Calif. -- California has begun to see concerning upticks in coronavirus data after a period of decline. The state health secretary said Friday that there have been increases in the number of newly confirmed cases, hospital emergency department visits for COVID-19 and new hospitalizations for...
Novavax, Endo rise; Cavco, Occidental Petroleum fall
NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday: Novavax Inc., up $11.12 to $113.56. The biotechnology company started a key study in the United Kingdom for a potential COVID-19 vaccine. Colony Capital Inc., up 29 cents to $2.63. The real estate investment firm is selling some of...
Stocks post solid gains as technology shares lead rally
Stocks shook off another bout of volatile trading and finished solidly higher Friday, led by gains in technology and health care companies. Despite the rally, the S&P 500 still posted its fourth straight weekly loss, extending Wall Street's September swoon. The S&P 500 rose 1.6% after flip-flopping...
Drugmaker Novavax begins late-stage vaccine trial in UK
LONDON (AP) — U.S.-based Novavax has begun a late stage trial of its potential COVID-19 vaccine in the United Kingdom because the high-level of the coronavirus circulating in the country is likely to produce quick results, the pharmaceutical company said. Novavax plans to test the effectiveness of its...
China aims to make 1 billion COVID-19 vaccine doses a year
BEIJING (AP) — A Chinese health official said Friday that the country's annual production capacity for coronavirus vaccines will top 1 billion doses next year, following an aggressive government support program for construction of new factories. Capacity is expected to reach 610 million doses by the end of...
The Latest: $14M more in virus funds for 3 Ariz universities
PHOENIX — Arizona will provide the state’s three public universities with $14 million in additional funding to boost their efforts to test, track and respond to the coronavirus. Gov. Doug Ducey said Thursday the money will help the universities build on their current efforts to track and contain...
Chinese company says coronavirus vaccine ready by early 2021
BEIJING (AP) — A Chinese pharmaceutical company said Thursday the coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide, including the United States. Yin Weidong, the CEO of SinoVac, vowed to apply to the U.S. Food and Drug Administration to sell CoronaVac in the...
Drug companies work jointly to boost vaccine confidence
LONDON (AP) — Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence that any approved vaccine will be safe. AstraZeneca CEO Pascal...
LOADING MORE STORIES
